$CNO
CNO Financial Group, Inc. Stock $cno

$cno Overview Financials Valuation SEC Filings Company Website

2018 Q2 Form 10-Q Financial Statement

#000122460818000035 Filed on August 03, 2018

Income Statement

Concept	2018 Q2	2017 Q2
Revenue	$1.046B	$1.057B
YoY Change	-1.02%	5.3%
Cost Of Revenue	$618.2M	$634.2M
YoY Change	-2.52%	0.28%
Gross Profit	$428.1M	$422.9M
YoY Change	1.23%	13.84%
Gross Profit Margin	40.92%	40.01%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$875.0M	$897.2M
YoY Change	-2.47%	0.55%
Operating Profit	$104.1M	-$474.3M
YoY Change	-121.95%	-8.93%
Interest Expense	$37.70M	$31.40M
YoY Change	20.06%	8.65%
% of Operating Profit	36.22%
Other Income/Expense, Net
YoY Change
Pretax Income	$129.8M	$128.5M
YoY Change	1.01%	55.38%
Income Tax	$27.60M	$45.10M
% Of Pretax Income	21.26%	35.1%
Net Earnings	$102.2M	$83.40M
YoY Change	22.54%	39.23%
Net Earnings / Revenue	9.77%	7.89%
Basic Earnings Per Share	$0.62	$0.49
Diluted Earnings Per Share	$0.61	$0.48
COMMON SHARES
Basic Shares Outstanding	166.1M shares	170.6M shares
Diluted Shares Outstanding	168.0M shares	172.4M shares

Balance Sheet

Concept	2018 Q2	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$745.7M	$939.9M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$26.96B	$26.88B
YoY Change	0.28%	3.4%
Other Assets	$485.0M	$594.0M
YoY Change	-18.35%	-12.39%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$32.47B	$32.84B
YoY Change	-1.13%	2.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$3.980B	$4.094B
YoY Change	-2.78%	-1.96%
Other Long-Term Liabilities	$654.0M	$867.0M
YoY Change	-24.57%	18.6%
Total Long-Term Liabilities	$4.634B	$4.961B
YoY Change	-6.59%	1.1%
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities	$4.634B	$4.961B
Total Liabilities	$28.02B	$28.06B
YoY Change	-0.16%	1.8%
SHAREHOLDERS EQUITY
Retained Earnings	$731.2M	$766.4M
YoY Change	-4.59%	80.08%
Common Stock	$3.024B	$3.118B
YoY Change	-3.04%	-4.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.455B	$4.779B
YoY Change
Total Liabilities & Shareholders Equity	$32.47B	$32.84B
YoY Change	-1.13%	2.56%

Cashflow Statement

Concept	2018 Q2	2017 Q2
OPERATING ACTIVITIES
Net Income	$102.2M	$83.40M
YoY Change	22.54%	39.23%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$171.5M	$142.6M
YoY Change	20.27%	-27.28%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$142.8M	$59.40M
YoY Change	-340.4%	-115.55%
Cash From Investing Activities	-$142.8M	$59.40M
YoY Change	-340.4%	-115.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-9.400M	-146.8M
YoY Change	-93.6%	1074.4%
NET CHANGE
Cash From Operating Activities	171.5M	142.6M
Cash From Investing Activities	-142.8M	59.40M
Cash From Financing Activities	-9.400M	-146.8M
Net Change In Cash	19.30M	55.20M
YoY Change	-65.04%	-127.81%
FREE CASH FLOW
Cash From Operating Activities	$171.5M	$142.6M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.12
CY2017Q4	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-295800000	USD
CY2018Q2	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-7500000	USD
CY2017Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts	-292600000	USD
CY2018Q2	cno	Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts	-100400000	USD
CY2017Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits	-94000000	USD
CY2018Q2	cno	Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits	-82400000	USD
CY2017Q4	cno	Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities	-335400000	USD
CY2018Q2	cno	Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities	-192100000	USD
CY2017Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation Depreciation On Fixed Maturity Securities Available For Sale When Other Than Temporary Impairment Loss Was Recognized AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationDepreciationOnFixedMaturitySecuritiesAvailableForSaleWhenOtherThanTemporaryImpairmentLossWasRecognized	2600000	USD
CY2018Q2	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation Depreciation On Fixed Maturity Securities Available For Sale When Other Than Temporary Impairment Loss Was Recognized AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationDepreciationOnFixedMaturitySecuritiesAvailableForSaleWhenOtherThanTemporaryImpairmentLossWasRecognized	2400000	USD
CY2017Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Gains Losses On All Other Investments AccumulatedOtherComprehensiveIncomeLossNetUnrealizedGainsLossesOnAllOtherInvestments	2227300000	USD
CY2018Q2	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Gains Losses On All Other Investments AccumulatedOtherComprehensiveIncomeLossNetUnrealizedGainsLossesOnAllOtherInvestments	1080200000	USD
CY2018Q2	cno	Aggregate Growth Rateforthe Next Five Years Includedin Deferred Tax Valuation Analysis AggregateGrowthRatefortheNextFiveYearsIncludedinDeferredTaxValuationAnalysis	0.03
CY2017Q2	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	300000	USD
	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	300000	USD
CY2018Q2	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	400000	USD
	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	400000	USD
CY2018Q2	cno	Available For Sale Fixed Maturities With Significant Unobservable Inputs Investment Grade Percent AvailableForSaleFixedMaturitiesWithSignificantUnobservableInputsInvestmentGradePercent	0.59
CY2018Q2	cno	Available For Sale Maturities With Significant Unobservable Inputs Corporate Securities Percent AvailableForSaleMaturitiesWithSignificantUnobservableInputsCorporateSecuritiesPercent	0.89
CY2017Q4	cno	Available For Sale Securities Debt Maturities Amortized Cost Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostExcludingStructuredSecurities	15334100000	USD
CY2018Q2	cno	Available For Sale Securities Debt Maturities Amortized Cost Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostExcludingStructuredSecurities	15839200000	USD
CY2017Q4	cno	Available For Sale Securities Debt Maturities Fair Value Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesFairValueExcludingStructuredSecurities	17275500000	USD
CY2018Q2	cno	Available For Sale Securities Debt Maturities Fair Value Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesFairValueExcludingStructuredSecurities	16715200000	USD
	cno	Available For Sale Securities Other Than Temporary Impairments Included In Accumulated Other Comprehensive Income Loss AvailableForSaleSecuritiesOtherThanTemporaryImpairmentsIncludedInAccumulatedOtherComprehensiveIncomeLoss	-800000	USD
	cno	Available For Sale Securities Value Of Securities Sold AvailableForSaleSecuritiesValueOfSecuritiesSold	760200000	USD
CY2017Q2	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	908500000	USD
	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	1864200000	USD
CY2018Q2	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	916000000	USD
	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	1827000000	USD
CY2017Q4	cno	Borrowings Related To Variable Interest Entities BorrowingsRelatedToVariableInterestEntities	1410700000	USD
CY2018Q2	cno	Borrowings Related To Variable Interest Entities BorrowingsRelatedToVariableInterestEntities	1418100000	USD
CY2017Q4	cno	Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities	578400000	USD
CY2018Q2	cno	Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities	639300000	USD
CY2017Q4	cno	Cash And Cash Equivalents Held By Variable Interest Entities CashAndCashEquivalentsHeldByVariableInterestEntities	178900000	USD
CY2018Q2	cno	Cash And Cash Equivalents Held By Variable Interest Entities CashAndCashEquivalentsHeldByVariableInterestEntities	106400000	USD
	cno	Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments	-124100000	USD
	cno	Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments	-58900000	USD
	cno	Change In Cash And Cash Equivalents Held By Variable Interest Entities ChangeInCashAndCashEquivalentsHeldByVariableInterestEntities	0	USD
CY2017Q4	cno	Debt Securities Availableforsale Continuous Unrealized Loss Position12 Monthsor Longer DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPosition12MonthsorLonger	732600000	USD
CY2018Q2	cno	Debt Securities Availableforsale Continuous Unrealized Loss Position12 Monthsor Longer DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPosition12MonthsorLonger	532100000	USD
CY2017Q4	cno	Debt Securities Availableforsale Continuous Unrealized Loss Position12 Monthsor Longer Accumulated Loss DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPosition12MonthsorLongerAccumulatedLoss	31400000	USD
CY2018Q2	cno	Debt Securities Availableforsale Continuous Unrealized Loss Position12 Monthsor Longer Accumulated Loss DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPosition12MonthsorLongerAccumulatedLoss	47000000	USD
CY2017Q4	cno	Debt Securities Availableforsale Continuous Unrealized Loss Position Lessthan12 Months DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionLessthan12Months	1426400000	USD
CY2018Q2	cno	Debt Securities Availableforsale Continuous Unrealized Loss Position Lessthan12 Months DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionLessthan12Months	5814900000	USD
CY2017Q4	cno	Debt Securities Availableforsale Continuous Unrealized Loss Position Lessthan12 Months Accumulated Loss DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionLessthan12MonthsAccumulatedLoss	11100000	USD
CY2018Q2	cno	Debt Securities Availableforsale Continuous Unrealized Loss Position Lessthan12 Months Accumulated Loss DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionLessthan12MonthsAccumulatedLoss	217600000	USD
CY2017Q4	cno	Debt Securities Availableforsale Unrealized Loss Position DebtSecuritiesAvailableforsaleUnrealizedLossPosition	2159000000	USD
CY2018Q2	cno	Debt Securities Availableforsale Unrealized Loss Position DebtSecuritiesAvailableforsaleUnrealizedLossPosition	6347000000	USD
CY2017Q4	cno	Debt Securities Availableforsale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableforsaleUnrealizedLossPositionAccumulatedLoss	42500000	USD
CY2018Q2	cno	Debt Securities Availableforsale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableforsaleUnrealizedLossPositionAccumulatedLoss	264600000	USD
CY2017Q4	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	366900000	USD
CY2018Q2	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	484800000	USD
CY2017Q4	cno	Deferred Tax Assets Before Valuation Allowance DeferredTaxAssetsBeforeValuationAllowance	465300000	USD
CY2018Q2	cno	Deferred Tax Assets Before Valuation Allowance DeferredTaxAssetsBeforeValuationAllowance	573500000	USD
CY2018Q2	cno	Distribution Expense Included In Other Costs And Expenses DistributionExpenseIncludedInOtherCostsAndExpenses	900000	USD
	cno	Distribution Expense Included In Other Costs And Expenses DistributionExpenseIncludedInOtherCostsAndExpenses	12400000	USD
CY2017Q2	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	-1300000	USD
	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	-2400000	USD
CY2018Q2	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	2100000	USD
	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	7900000	USD
CY2017Q4	cno	Equity Securities Fvni EquitySecuritiesFVNI	440600000	USD
CY2018Q2	cno	Equity Securities Fvni EquitySecuritiesFVNI	366100000	USD
CY2017Q4	cno	Equity Securities Fvni Cost EquitySecuritiesFVNICost	420000000	USD
CY2018Q2	cno	Equity Securities Fvni Cost EquitySecuritiesFVNICost	367100000	USD
	cno	Estimated Normalized Annual Taxable Income For Current Year EstimatedNormalizedAnnualTaxableIncomeForCurrentYear	345000000	USD
	cno	Estimated Normalized Annual Taxable Income For Current Year Life Income EstimatedNormalizedAnnualTaxableIncomeForCurrentYearLifeIncome	260000000	USD
	cno	Estimated Normalized Annual Taxable Income For Current Year Nonlife Taxable Income EstimatedNormalizedAnnualTaxableIncomeForCurrentYearNonlifeTaxableIncome	85000000	USD
CY2017Q2	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	13900000	USD
	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	27800000	USD
CY2018Q2	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	19400000	USD
	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	33200000	USD
CY2017Q2	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	0	USD
	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	0	USD
CY2018Q2	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	11000000	USD
	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	11000000	USD
	cno	Fair Value Fixed Maturity Securities Valued Using Broker Quotes Percentage FairValueFixedMaturitySecuritiesValuedUsingBrokerQuotesPercentage	0.31
CY2018Q2	cno	Federal Long Term Tax Exempt Rate FederalLongTermTaxExemptRate	0.0231
CY2018Q2	cno	Feerevenuerelatedtodistributionandmarketingagreements Feerevenuerelatedtodistributionandmarketingagreements	6600000	USD
	cno	Feerevenuerelatedtodistributionandmarketingagreements Feerevenuerelatedtodistributionandmarketingagreements	22400000	USD
	cno	Future Cash Tax Payments As A Percent Of Life Insurance Taxable Income Due FutureCashTaxPaymentsAsAPercentOfLifeInsuranceTaxableIncomeDue	0.65
	cno	Gain Losson Investments Excluding Cash Expenses GainLossonInvestmentsExcludingCashExpenses	23100000	USD
	cno	Gain Losson Investments Excluding Cash Expenses GainLossonInvestmentsExcludingCashExpenses	-4200000	USD
CY2018Q2	cno	Income Loss From Continuing Operations Before Investment Losses And Income Taxes IncomeLossFromContinuingOperationsBeforeInvestmentLossesAndIncomeTaxes	5700000	USD
	cno	Income Loss From Continuing Operations Before Investment Losses And Income Taxes IncomeLossFromContinuingOperationsBeforeInvestmentLossesAndIncomeTaxes	10000000	USD
CY2018Q2	cno	Increase To Deferred Tax Assets Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized IncreaseToDeferredTaxAssetsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	25100000	USD
	cno	Insurance Policy Benefits InsurancePolicyBenefits	1007900000	USD
	cno	Insurance Policy Benefits InsurancePolicyBenefits	1032800000	USD
CY2017Q4	cno	Investment Borrowings InvestmentBorrowings	1646700000	USD
CY2018Q2	cno	Investment Borrowings InvestmentBorrowings	1646300000	USD
CY2017Q4	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1526900000	USD
CY2018Q2	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1543300000	USD
CY2018Q2	cno	Investments Held In Limited Partnerships InvestmentsHeldInLimitedPartnerships	508600000	USD
CY2018Q2	cno	Loss Limitation Based On Income Of Life Insurance Company LossLimitationBasedOnIncomeOfLifeInsuranceCompany	0.35
CY2018Q2	cno	Loss Limitation Based On Loss Of Non Life Entities LossLimitationBasedOnLossOfNonLifeEntities	0.35
	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	1808500000	USD
	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	1412000000	USD
CY2017Q2	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	322400000	USD
	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	634400000	USD
CY2018Q2	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	328200000	USD
	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	657300000	USD
CY2017Q2	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	43900000	USD
	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	119100000	USD
CY2018Q2	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	35700000	USD
	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	48500000	USD
	cno	Net Sales Of Trading Securities NetSalesOfTradingSecurities	-74800000	USD
	cno	Net Sales Of Trading Securities NetSalesOfTradingSecurities	-36300000	USD
	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale	-2700000	USD
	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale	200000	USD
	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax	1500000	USD
	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax	-100000	USD
	cno	Number Of Insurance Subsidiaries That Are Members Of The Federal Home Loan Bank NumberOfInsuranceSubsidiariesThatAreMembersOfTheFederalHomeLoanBank	3	subsidiary
CY2018Q2	cno	Number Of Investments Held By Variable Interest Entities In Default NumberOfInvestmentsHeldByVariableInterestEntitiesInDefault	0	investment
	cno	Number Of Product Distribution Channels NumberOfProductDistributionChannels	3	distribution_channel
	cno	Number Of States Participating In Examination Of Compliance With Unclaimed Property Laws NumberOfStatesParticipatingInExaminationOfComplianceWithUnclaimedPropertyLaws	39	state
CY2017Q3	cno	Numberof Individuals Appointedto Assume Immediate Controland Power Over Affairs NumberofIndividualsAppointedtoAssumeImmediateControlandPowerOverAffairs	2	individual
CY2017Q2	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	31300000	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	23500000	USD
CY2018Q2	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	-33000000	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	-88700000	USD
CY2017Q2	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-160000000	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-212000000	USD
CY2018Q2	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	191400000	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	403000000	USD
CY2017Q2	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	300000	USD
	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	300000	USD
CY2018Q2	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	400000	USD
	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	400000	USD
CY2018Q2	cno	Ownership Change Threshold Restricting Net Operating Loss Usage OwnershipChangeThresholdRestrictingNetOperatingLossUsage	0.5
	cno	Policy Acquisition Costs PolicyAcquisitionCosts	126600000	USD
	cno	Policy Acquisition Costs PolicyAcquisitionCosts	125600000	USD
CY2017Q4	cno	Prepaid Accrued Income Taxes Current PrepaidAccruedIncomeTaxesCurrent	-9300000	USD
CY2018Q2	cno	Prepaid Accrued Income Taxes Current PrepaidAccruedIncomeTaxesCurrent	400000	USD
CY2017Q2	cno	Pretaxoperatingearnings Pretaxoperatingearnings	121100000	USD
	cno	Pretaxoperatingearnings Pretaxoperatingearnings	214000000	USD
CY2018Q2	cno	Pretaxoperatingearnings Pretaxoperatingearnings	104100000	USD
	cno	Pretaxoperatingearnings Pretaxoperatingearnings	199000000	USD
	cno	Proceeds From Investment Borrowings Related To Variable Interest Entities ProceedsFromInvestmentBorrowingsRelatedToVariableInterestEntities	30700000	USD
	cno	Proceeds From Investment Borrowings Related To Variable Interest Entities ProceedsFromInvestmentBorrowingsRelatedToVariableInterestEntities	277600000	USD
	cno	Purchases Of Investments PurchasesOfInvestments	2584800000	USD
	cno	Purchases Of Investments PurchasesOfInvestments	3689100000	USD
CY2018Q2	cno	Reduction To Deferred Acquisition Costs Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized ReductionToDeferredAcquisitionCostsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	28200000	USD
CY2018Q2	cno	Reduction To Present Value Of Future Profits Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized ReductionToPresentValueOfFutureProfitsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	75800000	USD
	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	164900000	USD
	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	274900000	USD
CY2017Q2	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	1029600000	USD
	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	2078200000	USD
CY2018Q2	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	1020100000	USD
	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	2026000000	USD
CY2017Q2	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	12300000	USD
	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	26500000	USD
CY2018Q2	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	15200000	USD
	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	32300000	USD
	cno	Sales Of Investments SalesOfInvestments	880400000	USD
	cno	Sales Of Investments SalesOfInvestments	2012900000	USD
	cno	Share Based Compensation Noncash Portion ShareBasedCompensationNoncashPortion	12100000	USD
	cno	Share Based Compensation Noncash Portion ShareBasedCompensationNoncashPortion	14100000	USD
	cno	Stock Based Compensation StockBasedCompensation	15600000	USD
	cno	Stock Based Compensation StockBasedCompensation	9000000	USD
CY2018Q2	cno	Stock Repurchase Program Remaining Repurchase Authorized Amount StockRepurchaseProgramRemainingRepurchaseAuthorizedAmount	325100000	USD
CY2017Q4	cno	Tax Cutsand Jobs Actof2017 Incomplete Accounting Changein Tax Rate Provisional Income Tax Expense Benefit TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpenseBenefit	172500000	USD
CY2017	cno	Tax Cutsand Jobs Actof2017 Incomplete Accounting Changein Tax Rate Provisional Income Tax Expense Benefit TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpenseBenefit	172500000	USD
	cno	Total Other Than Temporary Impairment Losses On Investments Held By Variable Interest Entities TotalOtherThanTemporaryImpairmentLossesOnInvestmentsHeldByVariableInterestEntities	400000	USD
CY2018Q2	cno	Unfunded Commitmentsto Limited Partnerships UnfundedCommitmentstoLimitedPartnerships	252100000	USD
	cno	Valuation Allowance Deferred Tax Asset Valuation Model Forecast Periodof Model ValuationAllowanceDeferredTaxAssetValuationModelForecastPeriodofModel	P5Y
	cno	Variable Interest Entities Investments Sold VariableInterestEntitiesInvestmentsSold	72800000	USD
	cno	Variable Interest Entities Investments Sold VariableInterestEntitiesInvestmentsSold	44000000	USD
	cno	Variable Interest Entities Net Gain Loss From Sale Of Fixed Maturity Investments VariableInterestEntitiesNetGainLossFromSaleOfFixedMaturityInvestments	2300000	USD
	cno	Variable Interest Entities Net Realized Gain Loss On Investments VariableInterestEntitiesNetRealizedGainLossOnInvestments	1800000	USD
	cno	Variable Interest Entities Net Realized Gain Loss On Investments VariableInterestEntitiesNetRealizedGainLossOnInvestments	2900000	USD
CY2018Q2	cno	Variable Interest Entity Amortized Cost Securities Held VariableInterestEntityAmortizedCostSecuritiesHeld	1550600000	USD
CY2018Q2	cno	Variable Interest Entity Fixed Maturity Securities Fair Value VariableInterestEntityFixedMaturitySecuritiesFairValue	1543300000	USD
CY2017Q2	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	-3700000	USD
	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	-3700000	USD
CY2018Q2	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	0	USD
	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	0	USD
CY2018Q2	cno	Variable Interest Entity Gross Unrealized Gains Fixed Maturity Securities VariableInterestEntityGrossUnrealizedGainsFixedMaturitySecurities	3800000	USD
CY2018Q2	cno	Variable Interest Entity Gross Unrealized Losses Fixed Maturity Securities VariableInterestEntityGrossUnrealizedLossesFixedMaturitySecurities	11100000	USD
	cno	Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax	1800000	USD
	cno	Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax	3100000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-06-30
	dei	Entity Central Index Key EntityCentralIndexKey	0001224608
CY2018Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	164566061	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	CNO Financial Group, Inc.
CY2017Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	245900000	USD
CY2018Q2	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	252500000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1212100000	USD
CY2018Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	700200000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1195800000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3073300000	USD
CY2018Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3021900000	USD
CY2017Q2	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	59600000	USD
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	123100000	USD
CY2018Q2	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	61000000	USD
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	132900000	USD
CY2017Q4	us-gaap	Assets Assets	33110300000	USD
CY2018Q2	us-gaap	Assets Assets	32472200000	USD
CY2017Q2	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	7700000	USD
	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	15700000	USD
CY2018Q2	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	7000000	USD
	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	14200000	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	20702100000	USD
CY2018Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	20989500000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	1508700000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	1828200000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	1601300000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	1860500000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1947300000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1666300000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	2052300000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1720700000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	11550000000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	11966200000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	13286800000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	12749100000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	328100000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	378500000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	335100000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	384900000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	5368000000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	5150300000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	5635400000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	5365700000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	22910900000	USD
CY2018Q2	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	9300000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	22080900000	USD
CY2017Q2	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	928600000	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	1902600000	USD
CY2018Q2	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	916500000	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	1816200000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	668200000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	939900000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	757300000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	745700000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	271700000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-11600000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	668200000	USD
CY2017Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	939900000	USD
CY2017Q2	us-gaap	Ceded Premiums Written CededPremiumsWritten	26500000	USD
	us-gaap	Ceded Premiums Written CededPremiumsWritten	52800000	USD
CY2018Q2	us-gaap	Ceded Premiums Written CededPremiumsWritten	26100000	USD
	us-gaap	Ceded Premiums Written CededPremiumsWritten	50600000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.09
CY2018Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.19
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	166857931	shares
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	164433085	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	166857931	shares
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	164433085	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	1700000	USD
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	1600000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	248300000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	417800000	USD
CY2018Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-91900000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-309100000	USD
CY2016Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	300000	USD
CY2017Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	0	USD
CY2017Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	22000000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	42600000	USD
CY2018Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	15400000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	20700000	USD
CY2017Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	914600000	USD
CY2018Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	915700000	USD
CY2017Q4	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	10400000	USD
CY2017Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	23100000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	36900000	USD
CY2018Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	12200000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	30700000	USD
CY2017Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1026800000	USD
CY2018Q2	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1237400000	USD
	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	1000000	USD
	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	2800000	USD
	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	4300000	USD
	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	5100000	USD
CY2017Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	42500000	USD
CY2018Q2	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	40200000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	967900000	USD
CY2018Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	930600000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	4300000	USD
CY2018Q2	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	376200000	USD
CY2018Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	484400000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	489600000	USD
CY2018Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	468700000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	9300000	USD
CY2018Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	9100000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	48900000	USD
CY2018Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	47500000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities	415800000	USD
CY2018Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities	405300000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	89100000	USD
CY2018Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	89100000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	502600000	USD
CY2018Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	357100000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	165400000	USD
CY2018Q2	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	159600000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	0	USD
CY2018Q2	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	3300000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	337200000	USD
CY2018Q2	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	194200000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	136200000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	146700000	USD
CY2017Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	24200000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	71700000	USD
CY2018Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	27900000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	56600000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	29400000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	32000000	USD
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.49
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.85
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.62
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.48
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.84
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.61
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.10
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.353
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.216
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.014
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.002
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.017
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.008
CY2017Q2	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-7200000	USD
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-12700000	USD
CY2018Q2	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	10400000	USD
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	41300000	USD
CY2017Q2	us-gaap	Fees And Commissions FeesAndCommissions	11500000	USD
	us-gaap	Fees And Commissions FeesAndCommissions	23300000	USD
CY2018Q2	us-gaap	Fees And Commissions FeesAndCommissions	11600000	USD
	us-gaap	Fees And Commissions FeesAndCommissions	32800000	USD
CY2017Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	15200000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	23100000	USD
CY2018Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	11000000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-4200000	USD
CY2017Q2	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	24000000	USD
	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	40300000	USD
CY2018Q2	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	11000000	USD
	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	-4200000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	880400000	USD
CY2017Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3800000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3800000	USD
CY2017Q2	us-gaap	Impairment Of Investments ImpairmentOfInvestments	5100000	USD
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	13500000	USD
CY2018Q2	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	128500000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	225200000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	129800000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	237900000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	45100000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	79500000	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27600000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	51400000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	33700000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	30400000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	45800000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	21000000	USD
	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	126600000	USD
	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	125600000	USD
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	222800000	USD
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	94400000	USD
CY2017Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1796000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1714000	shares
CY2018Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1880000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2249000	shares
CY2017Q2	us-gaap	Interest Expense InterestExpense	31400000	USD
	us-gaap	Interest Expense InterestExpense	62200000	USD
CY2018Q2	us-gaap	Interest Expense InterestExpense	37700000	USD
	us-gaap	Interest Expense InterestExpense	71300000	USD
	us-gaap	Interest Paid InterestPaid	61000000	USD
	us-gaap	Interest Paid InterestPaid	65600000	USD
CY2017Q4	us-gaap	Investments Investments	27854100000	USD
CY2018Q2	us-gaap	Investments Investments	26955900000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	28262800000	USD
CY2018Q2	us-gaap	Liabilities Liabilities	28017300000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33110300000	USD
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32472200000	USD
CY2017Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	530300000	USD
CY2018Q2	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	499500000	USD
CY2017Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	11521300000	USD
CY2018Q2	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	11268500000	USD
CY2018Q2	us-gaap	Long Term Debt LongTermDebt	925000000	USD
CY2018Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	500000000	USD
CY2018Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2018Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2018Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2018Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2018Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	425000000	USD
CY2017Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	1650600000	USD
CY2018Q2	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	1649400000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-180700000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-14400000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	166400000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-240900000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	286000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	243700000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	83400000	USD
	us-gaap	Net Income Loss NetIncomeLoss	145700000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	102200000	USD
	us-gaap	Net Income Loss NetIncomeLoss	186500000	USD
	us-gaap	Net Investment Income NetInvestmentIncome	629400000	USD
CY2017Q4	us-gaap	Notes Payable NotesPayable	914600000	USD
CY2018Q2	us-gaap	Notes Payable NotesPayable	915700000	USD
CY2018Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2231900000	USD
CY2017Q4	us-gaap	Other Assets OtherAssets	319500000	USD
CY2018Q2	us-gaap	Other Assets OtherAssets	318200000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	255600000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	422100000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-247800000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-634600000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	164900000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	272100000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-194100000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-495600000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	11200000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	16300000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	11300000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	11700000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	90700000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	150000000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-53700000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-139000000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	457800000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	673600000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-461300000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-1115000000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	269400000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-495400000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	148500000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-138900000	USD
CY2017Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	203400000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	413800000	USD
CY2018Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	195800000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	403400000	USD
CY2017Q4	us-gaap	Other Investments OtherInvestments	924500000	USD
CY2018Q2	us-gaap	Other Investments OtherInvestments	946000000	USD
CY2017Q4	us-gaap	Other Liabilities OtherLiabilities	751800000	USD
CY2018Q2	us-gaap	Other Liabilities OtherLiabilities	654200000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	9300000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-28400000	USD
CY2017Q2	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	900000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	900000	USD
CY2018Q2	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	0	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	0	USD
CY2017Q2	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	4200000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	12600000	USD
CY2018Q2	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	0	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	0	USD
	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	394700000	USD
	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	425100000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	12500000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	13000000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	111100000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	67500000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	29300000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	31900000	USD
CY2017Q4	us-gaap	Policy Loans Receivable PolicyLoansReceivable	116000000	USD
CY2018Q2	us-gaap	Policy Loans Receivable PolicyLoansReceivable	116000000	USD
CY2017Q2	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	634200000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	1303500000	USD
CY2018Q2	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	618200000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	1204800000	USD
CY2017Q4	us-gaap	Policyholder Funds PolicyholderFunds	11220700000	USD
CY2018Q2	us-gaap	Policyholder Funds PolicyholderFunds	11349700000	USD
CY2017Q2	us-gaap	Premiums Earned Net PremiumsEarnedNet	664100000	USD
	us-gaap	Premiums Earned Net PremiumsEarnedNet	1327900000	USD
CY2018Q2	us-gaap	Premiums Earned Net PremiumsEarnedNet	659800000	USD
	us-gaap	Premiums Earned Net PremiumsEarnedNet	1319700000	USD
	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	727800000	USD
	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	753200000	USD
	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	132000000	USD
	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	0	USD
	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	23300000	USD
	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	32800000	USD
	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	1257200000	USD
	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	1243500000	USD
	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	629400000	USD
	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	646900000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5400000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	800000	USD
CY2017Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	15200000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	23100000	USD
CY2018Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	11000000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-4200000	USD
CY2017Q2	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	11500000	USD
	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	23500000	USD
CY2018Q2	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	8700000	USD
	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	18000000	USD
CY2017Q2	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	22400000	USD
	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	46500000	USD
CY2018Q2	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	20800000	USD
	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	44200000	USD
CY2017Q4	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	2175200000	USD
CY2018Q2	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	2127400000	USD
	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	638900000	USD
	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	671300000	USD
	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	132400000	USD
	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	400000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	560400000	USD
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	731200000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	576700000	USD
CY2017Q2	us-gaap	Revenues Revenues	1057100000	USD
	us-gaap	Revenues Revenues	2127800000	USD
CY2018Q2	us-gaap	Revenues Revenues	1046300000	USD
	us-gaap	Revenues Revenues	2054100000	USD
CY2017Q4	us-gaap	Separate Account Assets SeparateAccountAssets	5000000	USD
CY2018Q2	us-gaap	Separate Account Assets SeparateAccountAssets	4800000	USD
CY2017Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	5000000	USD
CY2018Q2	us-gaap	Separate Accounts Liability SeparateAccountsLiability	4800000	USD
	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	235000	shares
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	111900000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	60500000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	4486900000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	4779300000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	4847500000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	4454900000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	4847500000	USD
CY2017Q4	us-gaap	Trading Securities TradingSecurities	284600000	USD
CY2018Q2	us-gaap	Trading Securities TradingSecurities	254200000	USD
CY2017Q4	us-gaap	Unearned Premiums UnearnedPremiums	261700000	USD
CY2018Q2	us-gaap	Unearned Premiums UnearnedPremiums	260500000	USD
CY2017Q4	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	359600000	USD
CY2018Q2	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	345500000	USD
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	172352000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	172352000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	173708000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	173708000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	167978000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	167978000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	168828000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	168828000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	170556000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	170556000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	171994000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	171994000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	166098000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	166098000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	166579000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	166579000	shares
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LITIGATION AND OTHER LEGAL PROCEEDINGS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Legal Proceedings</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company and its subsidiaries are involved in various legal actions in the normal course of business, in which claims for compensatory and punitive damages are asserted, some for substantial amounts.  We recognize an estimated loss from these loss contingencies when we believe it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Some of the pending matters have been filed as purported class actions and some actions have been filed in certain jurisdictions that permit punitive damage awards that are disproportionate to the actual damages incurred.  The amounts sought in certain of these actions are often large or indeterminate and the ultimate outcome of certain actions is difficult to predict.  In the event of an adverse outcome in one or more of these matters, there is a possibility that the ultimate liability may be in excess of the liabilities we have established and could have a material adverse effect on our business, financial condition, results of operations and cash flows.  In addition, the resolution of pending or future litigation may involve modifications to the terms of outstanding insurance policies or could impact the timing and amount of rate increases, which could adversely affect the future profitability of the related insurance policies.  Based upon information presently available, and in light of legal, factual and other defenses available to the Company and its subsidiaries, the Company does not believe that it is probable that the ultimate liability from either pending or threatened legal actions, after consideration of existing loss provisions, will have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows. However, given the inherent difficulty in predicting the outcome of legal proceedings, there exists the possibility that such legal actions could have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to the inherent difficulty of predicting litigation outcomes, particularly those that will be decided by a jury, some matters purport to seek substantial or an unspecified amount of damages for unsubstantiated conduct spanning several years based on complex legal theories and damages models. The alleged damages typically are indeterminate or not factually supported in the complaint, and, in any event, the Company's experience indicates that monetary demands for damages often bear little relation to the ultimate loss. In some cases, plaintiffs are seeking to certify classes in the litigation and class certification either has been denied or is pending and we have filed oppositions to class certification or sought to decertify a prior class certification. In addition, for many of these cases: (i) there is uncertainty as to the outcome of pending appeals or motions; (ii) there are significant factual issues to be resolved; and/or (iii) there are novel legal issues presented. Accordingly, the Company cannot reasonably estimate the possible loss or range of loss in excess of amounts accrued, if any, or predict the timing of the eventual resolution of these matters.  The Company reviews these matters on an ongoing basis.  When assessing reasonably possible and probable outcomes, the Company bases its assessment on the expected ultimate outcome following all appeals.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 29, 2016, Washington National and Bankers Conseco Life Insurance Company ("BCLIC") commenced an arbitration proceeding seeking compensatory, consequential and punitive damages against Beechwood Re Ltd. ("BRe") based upon BRe’s incurable material breaches of the long-term care reinsurance agreements, conversion, fraud, and breaches of fiduciary duties and the obligation to deal honestly and in good faith. BRe filed a counterclaim against Washington National and BCLIC in the arbitration alleging damages relating to the reinsurance agreements and their termination. In addition, on September 29, 2016, a complaint was filed by BCLIC and Washington National in the United States District Court for the Southern District of New York, Bankers Conseco Life Insurance Company and Washington National Insurance Company v. Moshe M. Feuer, Scott Taylor and David Levy, Case No. 16-cv-7646, alleging, among other claims, fraud/fraudulent concealment, and violation of the Racketeer Influenced and Corrupt Organizations Act. These allegations relate to the long-term care reinsurance agreements between BRe and Washington National and BCLIC, respectively, and emanate from the undisclosed relationships between and among the defendants (who were the principal owners and officers of BRe) and Platinum Partners, LP and its affiliates. On April 27, 2017, an amended complaint was filed adding Beechwood Capital Group, LLC as a defendant. On March 13, 2018, the District Court granted the motion that had been filed by Feuer, Taylor and Levy to compel arbitration of Washington National's and BCLIC's claims and the litigation is now stayed pending the outcome of the arbitration. Washington National and BCLIC intend to vigorously pursue their claims for damages and other remedies in the arbitration and the litigation described above.</font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By public notice dated July 26, 2017, the Cayman Islands Monetary Authority advised that, effective July 25, 2017, </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> individuals (the "Controllers") had been appointed pursuant to Section 24(2)(h) of the Cayman Islands Insurance Law to assume control of the affairs of BRe.  According to the public notice, effective with their appointment, the Controllers assumed immediate control of the affairs of BRe and have all the powers necessary to administer the affairs of BRe including power to terminate its insurance business.  The Controllers are responsible for assessing the financial position of BRe and submitting a report to the Cayman Islands Monetary Authority by a date to be specified.  We are in the process of assessing the potential impact of this action on the proceedings described in the foregoing paragraph.</font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Regulatory Examinations and Fines</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance companies face significant risks related to regulatory investigations and actions.  Regulatory investigations generally result from matters related to sales or underwriting practices, payment of contingent or other sales commissions, claim payments and procedures, product design, product disclosure, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, procedures related to canceling policies, changing the way cost of insurance charges are calculated for certain life insurance products or recommending unsuitable products to customers.  We are, in the ordinary course of our business, subject to various examinations, inquiries and information requests from state, federal and other authorities.  The ultimate outcome of these regulatory actions (including the costs of complying with information requests and policy reviews) cannot be predicted with certainty.  In the event of an unfavorable outcome in one or more of these matters, the ultimate liability may be in excess of liabilities we have established and we could suffer significant reputational harm as a result of these matters, which could also have a material adverse effect on our business, financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2011, we were notified of an examination to be done on behalf of a number of states for the purpose of determining compliance with unclaimed property laws by the Company and its subsidiaries.  Such examination has included inquiries related to the use of data available on the U.S. Social Security Administration's Death Master File to identify instances where benefits under life insurance policies, annuities and retained asset accounts are payable. We are continuing to provide information to the examiners in response to their requests. A total of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">39</font><font style="font-family:inherit;font-size:10pt;"> states and the District of Columbia are currently participating in this examination.</font></div></div>

Files In Submission

Name	View Source	Status
0001224608-18-000035-index-headers.html	Edgar Link	pending
0001224608-18-000035-index.html	Edgar Link	pending
0001224608-18-000035.txt	Edgar Link	pending
0001224608-18-000035-xbrl.zip	Edgar Link	pending
cno-20180630.xml	Edgar Link	completed
cno-20180630.xsd	Edgar Link	pending
cno-20180630_cal.xml	Edgar Link	unprocessable
cno-20180630_def.xml	Edgar Link	unprocessable
cno-20180630_lab.xml	Edgar Link	unprocessable
cno-20180630_pre.xml	Edgar Link	unprocessable
cno0630201810-q.htm	Edgar Link	pending
cno06302018ex121.htm	Edgar Link	pending
cno06302018ex311.htm	Edgar Link	pending
cno06302018ex312.htm	Edgar Link	pending
cno06302018ex321.htm	Edgar Link	pending
cno06302018ex322.htm	Edgar Link	pending
exhibit101-072018baude.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
orgchart2017.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CNO
CNO Financial Group, Inc. Stock $cno

2018 Q2 Form 10-Q Financial Statement

#000122460818000035 Filed on August 03, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNO CNO Financial Group, Inc. Stock $cno

2018 Q2 Form 10-Q Financial Statement

#000122460818000035 Filed on August 03, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNO
CNO Financial Group, Inc. Stock $cno